Levels of HMGB1 in the sera of ccRCC patients (16.16 ng/ml ± 4.708) were significantly higher than those of healthy controls (2.64 ng/ml ± 0.229) (p ≤ 0.0001) (Figure 1). Here, HMGB1 is linked to nonpapillary renal cell carcinoma.